-+ 0.00%
-+ 0.00%
-+ 0.00%

ADMA Biologics FY2026 Revenue expected to be more than $530.000M vs $535.360M Est

Benzinga·11/04/2026 21:16:36
Listen to the news
ADMA Biologics (NASDAQ:ADMA) FY2026 Revenue expected to be more than $530.000M vs $535.360M Est